Nestlé posts 2025 results, sharpens focus on coffee and RTD lines

Nestlé used its mid-February full-year 2025 results to sharpen strategy, reporting CHF 9.2 billion in free cash flow and flagging Coffee as a core growth pillar as it concentrates the business around four areas. CEO Philipp Navratil framed the year as proof that targeted actions are working, noting positive real internal growth across all Zones and a UTOP margin of 16.1%.

Navratil said, “I am encouraged by our performance during 2025, which reflects the targeted actions we have taken in a difficult external environment. Real internal growth (RIG) was positive across all Zones and global businesses. We increased our investment in marketing, delivered a UTOP margin of 16.1% and generated CHF 9.2 billion in free cash flow. Improving organic growth, RIG and market share trends in the second half show that our actions are working. [...] While there is more to be done, we are confident that our faster execution of a more focused strategy will deliver sustained improvement through 2026 and beyond.”

On headline numbers, industry coverage varied in tone. Gcrmag reported group sales fell 2% to CHF 89.49 billion (US$115.45 billion) and underlying trading operating profit declined 8.4% to CHF 14.39 billion (US$18.56 billion), while Nestlé’s materials described only a slight decline in group sales. Foodnavigator supplied the company’s detailed volume metrics, reporting organic growth of 3.5% for 2025 and RIG up 0.8%, and Nestlé guided organic sales growth of 3–4% for 2026 with RIG expected to accelerate.

Quarterly detail showed low single-digit growth in Q4 driven by Medical Nutrition and strong consumption in Orgain and Pure Encapsulations, partially offset by softness in Garden of Life and the discontinuation of some private label vitamins, minerals and supplements lines. Nestlé said Nestlé Health Science delivered RIG-led growth for the year, and the company has concluded a strategic review of mainstream and value VMS brands and is moving ahead to engage potential buyers for those parts of the business.

Strategic changes are concrete. Jamessharp and Nestlé materials said the group will sharpen its portfolio around four businesses, with Coffee, Petcare and Nutrition together representing 70% of sales and Food & Snacks kept as a leading regional position. Nestlé plans to integrate Nutrition and Nestlé Health Science into a single business, expand high-potential growth platforms to represent 30% of sales, upgrade marketing and innovation spending, and simplify the organization to drive efficiencies.

Nestlé also disclosed portfolio processes in progress: Jamessharp reported advanced negotiations to sell the remaining ice cream business to Froneri, and Foodnavigator said a formal process to engage partners for the Waters business kicked off earlier in Q1 with an expected deconsolidation in 2027. Gcrmag noted the company expects UTOP margin improvement and free cash flow above CHF 9 billion again in 2026.

The company published a suite of 2025 documents with the release, including Financial Statements 2025, Annual Review 2025 and regional language versions, and ran analyst and media webcasts on the day of the announcement. Where coverage differed, the more precise figures were reported by Gcrmag for sales and UTOP and by Foodnavigator for organic growth and RIG; Nestlé’s own framing underlined a shift toward concentrated brand investment and faster execution into 2026.